J.A. Mauri

739 total citations
21 papers, 451 citations indexed

About

J.A. Mauri is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, J.A. Mauri has authored 21 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 13 papers in Pediatrics, Perinatology and Child Health and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in J.A. Mauri's work include Epilepsy research and treatment (14 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Neuroscience and Neuropharmacology Research (6 papers). J.A. Mauri is often cited by papers focused on Epilepsy research and treatment (14 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Neuroscience and Neuropharmacology Research (6 papers). J.A. Mauri collaborates with scholars based in Spain, Palestinian Territory and Mexico. J.A. Mauri's co-authors include A. Molins, Vicente Villanueva, J. Rodríguez-Uranga, Francisco Javier López‐González, Manuel Toledo, Juan Luís Becerra, Rodrigo Rocamora, Rosa Maria Vivanco‐Hidalgo, Mercedes Garcés and José M. Serratosa and has published in prestigious journals such as Epilepsia, Neuroscience Letters and Headache The Journal of Head and Face Pain.

In The Last Decade

J.A. Mauri

21 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.A. Mauri Spain 13 329 276 173 88 39 21 451
Jan‐Peter Ernst Germany 5 463 1.4× 271 1.0× 237 1.4× 46 0.5× 43 1.1× 6 555
Clara Tonini Italy 7 343 1.0× 249 0.9× 159 0.9× 82 0.9× 29 0.7× 10 457
J. Rodríguez-Uranga Spain 11 310 0.9× 263 1.0× 160 0.9× 21 0.2× 22 0.6× 16 344
Peter Kinirons Ireland 11 239 0.7× 156 0.6× 144 0.8× 46 0.5× 86 2.2× 16 387
Rebekka Kretz Germany 12 403 1.2× 261 0.9× 169 1.0× 66 0.8× 20 0.5× 16 627
B. J. Steinhoff Germany 11 274 0.8× 236 0.9× 143 0.8× 25 0.3× 23 0.6× 33 329
G. Hosking United Kingdom 5 235 0.7× 233 0.8× 55 0.3× 22 0.3× 30 0.8× 7 309
Marcelo Bartuluchi Argentina 10 235 0.7× 162 0.6× 90 0.5× 52 0.6× 70 1.8× 23 349
Marc Boel Belgium 11 298 0.9× 206 0.7× 163 0.9× 21 0.2× 10 0.3× 17 454
J.C. Doelman Netherlands 7 255 0.8× 214 0.8× 81 0.5× 15 0.2× 17 0.4× 8 358

Countries citing papers authored by J.A. Mauri

Since Specialization
Citations

This map shows the geographic impact of J.A. Mauri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Mauri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Mauri more than expected).

Fields of papers citing papers by J.A. Mauri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. Mauri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Mauri. The network helps show where J.A. Mauri may publish in the future.

Co-authorship network of co-authors of J.A. Mauri

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. Mauri. A scholar is included among the top collaborators of J.A. Mauri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. Mauri. J.A. Mauri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santamarina, Estevo, Júlia Miró, Laura Abraira, et al.. (2019). Use of intravenous brivaracetam in status epilepticus: A multicenter registry. Epilepsia. 60(8). 1593–1601. 34 indexed citations
2.
Santamarina, Estevo, Júlia Miró, Laura Abraira, et al.. (2019). Experience of the use of Brivaracetam in status epilepticus (a Spanish multicentric registry). Epilepsy & Behavior. 101. 106798–106798. 1 indexed citations
3.
Toledo, Manuel, et al.. (2019). Levels of anger in epilepsy patients treated with eslicarbazepine acetate. Acta Neurologica Scandinavica. 140(1). 48–55. 1 indexed citations
4.
Santamarina, Estevo, Montserrat González‐Cuevas, Manuel Toledo, et al.. (2018). Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy. Epilepsy & Behavior. 84. 93–98. 20 indexed citations
5.
Villanueva, Vicente, Francisco Javier López‐González, J.A. Mauri, et al.. (2018). BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice. Acta Neurologica Scandinavica. 139(4). 360–368. 63 indexed citations
6.
Gómez‐Ibáñez, Asier, José M. Serratosa, Mercedes Garcés, et al.. (2017). Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case series. Seizure. 48. 53–56. 13 indexed citations
7.
Villanueva, Vicente, Rosa Ana Sáiz Díaz, Manuel Toledo, et al.. (2016). NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy. Epilepsy & Behavior. 65. 25–32. 34 indexed citations
8.
Garcés, Mercedes, Vicente Villanueva, J.A. Mauri, et al.. (2014). Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study. Epilepsy & Behavior. 36. 144–152. 30 indexed citations
9.
Villanueva, Vicente, Mercedes Garcés, José M. Serratosa, et al.. (2014). Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study. Clinical Drug Investigation. 35(2). 121–131. 30 indexed citations
10.
Rocamora, Rodrigo, et al.. (2014). Pilomotor seizures: An autonomic semiology of limbic encephalitis?. Seizure. 23(8). 670–673. 70 indexed citations
11.
Villanueva, Vicente, Francisco J. López, José M. Serratosa, et al.. (2013). Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide. Epilepsy & Behavior. 29(2). 349–356. 37 indexed citations
12.
Matías‐Guiu, Jorge, et al.. (2010). Acceptability and tolerability of levetiracetam oral solution forthe treatment of partial-onset seizures: the SOLUCIÓN study. Methods and Findings in Experimental and Clinical Pharmacology. 32(7). 507–507. 1 indexed citations
13.
Piñol‐Ripoll, Gerard, Lorena Fuentes‐Broto, J.A. Mauri, et al.. (2006). Protective effect of melatonin and pinoline on nitric oxide-induced lipid and protein peroxidation in rat brain homogenates. Neuroscience Letters. 405(1-2). 89–93. 16 indexed citations
14.
Ascaso, Francisco J., et al.. (2003). Visual field defects in pediatric patients on vigabatrin monotherapy. Documenta Ophthalmologica. 107(2). 127–130. 12 indexed citations
15.
Larrodé, P, et al.. (2000). Tratamiento con esteroides de la psicosis aguda relacionada con esclerosis múltiple. Revista de Neurología. 31(9). 841–841. 5 indexed citations
16.
Íñiguez, Cristina, et al.. (2000). Mielitis transversa aguda secundaria a la vacunación de la hepatitis B. Revista de Neurología. 31(5). 430–430. 14 indexed citations
17.
Larrodé, P, et al.. (2000). [Peripheral nervous system neurotoxicity secondary to chemotherapy treatment] .. PubMed. 15(8). 343–51. 2 indexed citations
18.
Mauri, J.A., et al.. (1999). Epilepsia sintomática: revisión de 208 pacientes. Revista de Neurología. 28(9). 846–846. 1 indexed citations
19.
Mauri, J.A., et al.. (1998). Long‐term Evolution of a Laughing Headache Associated With Chiari Type 1 Malformation. Headache The Journal of Head and Face Pain. 38(7). 552–553. 8 indexed citations
20.
Mauri, J.A., et al.. (1997). [Reading-induced epilepsy: three new cases].. PubMed. 25(137). 83–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026